Invesco
INO icon

Invesco’s Inovio Pharmaceuticals INO Stock Holding History

Invesco’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,779
Closed -$19.2K – 3807
2025
Q1 		$19.2K Sell
11,779
-258
-2% -$518 ﹤0.01% 3746
2024
Q4 		$22K Buy
12,037
+1,024
+9% +$4.53K ﹤0.01% 3738
2024
Q3 		$63.7K Sell
11,013
-482
-4% -$3.98K ﹤0.01% 3663
2024
Q2 		$92.9K Buy
+11,495
New +$121K ﹤0.01% 3762
2024
Q1 		– Sell
-27,805
Closed -$170K – 3899
2023
Q4 		$170K Buy
27,805
+265
+1% +$1.31K ﹤0.01% 3596
2023
Q3 		$129K Buy
27,540
+1,708
+7% +$9.43K ﹤0.01% 3688
2023
Q2 		$138K Sell
25,832
-3,595
-12% -$29K ﹤0.01% 3679
2023
Q1 		$290K Buy
29,427
+7,850
+36% +$134K ﹤0.01% 3509
2022
Q4 		$404K Buy
21,577
+889
+4% +$20.1K ﹤0.01% 3384
2022
Q3 		$428K Sell
20,688
-372
-2% -$9.52K ﹤0.01% 3327
2022
Q2 		$437K Buy
21,060
+2,885
+16% +$81.3K ﹤0.01% 3392
2022
Q1 		$783K Buy
18,175
+11,519
+173% +$519K ﹤0.01% 3189
2021
Q4 		$399K Sell
6,656
-1,057
-14% -$84.7K ﹤0.01% 3486
2021
Q3 		$662K Buy
7,713
+698
+10% +$70K ﹤0.01% 3296
2021
Q2 		$780K Buy
7,015
+2,932
+72% +$282K ﹤0.01% 3237
2021
Q1 		$455K Buy
4,083
+1,336
+49% +$176K ﹤0.01% 3380
2020
Q4 		$292K Sell
2,747
-329
-11% -$43.8K ﹤0.01% 3428
2020
Q3 		$429K Sell
3,076
-8,633
-74% -$1.8M ﹤0.01% 3188
2020
Q2 		$3.79M Buy
11,709
+760
+7% +$122K ﹤0.01% 2150
2020
Q1 		$977K Buy
10,949
+7,467
+214% +$460K ﹤0.01% 2733
2019
Q4 		$138K Sell
3,482
-236
-6% -$7.1K ﹤0.01% 3583
2019
Q3 		$91K Sell
3,718
-145
-4% -$4.41K ﹤0.01% 3631
2019
Q2 		$136K Sell
3,863
-5,331
-58% -$212K ﹤0.01% 3658
2019
Q1 		$412K Buy
9,194
+4,440
+93% +$224K ﹤0.01% 3378
2018
Q4 		$228K Sell
4,754
-992
-17% -$60.3K ﹤0.01% 3529
2018
Q3 		$383K Buy
5,746
+1,427
+33% +$79.5K ﹤0.01% 3532
2018
Q2 		$203K Buy
4,319
+2,778
+180% +$153K ﹤0.01% 3700
2018
Q1 		$87K Buy
1,541
+168
+12% +$9.09K ﹤0.01% 3671
2017
Q4 		$68K Buy
1,373
+44
+3% +$2.73K ﹤0.01% 3619
2017
Q3 		$101K Buy
1,329
+85
+7% +$6.33K ﹤0.01% 3610
2017
Q2 		$117K Buy
+1,244
New +$106K ﹤0.01% 3642
2016
Q4 		– Sell
-66,443
Closed -$7.43M – 3694
2016
Q3 		$7.43M Buy
66,443
+10,607
+19% +$1.17M ﹤0.01% 1696
2016
Q2 		$6.19M Buy
+55,836
New +$6.78M ﹤0.01% 1764
2015
Q3 		– Sell
-51
Closed -$5K – 3878
2015
Q2 		$5K Buy
+51
New +$5.45K ﹤0.01% 4198
2014
Q4 		– Sell
-699
Closed -$83K – 4086
2014
Q3 		$83K Sell
699
-263
-27% -$32.8K ﹤0.01% 3887
2014
Q2 		$125K Sell
962
-189
-16% -$22.3K ﹤0.01% 3877
2014
Q1 		$184K Sell
1,151
-160
-12% -$23K ﹤0.01% 3792
2013
Q4 		$182K Buy
+1,311
New +$131K ﹤0.01% 3832

Other funds holding INO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Invesco's INO Position: Q2 2025 in Review

Invesco sold out of Inovio Pharmaceuticals (INO) in Q2 2025, closing a stake of 11,779 shares — an estimated $19.2K sold.

Invesco first reported a position in INO in Q4 2013 and held it in 38 quarters. The position peaked at $7.43M in Q3 2016. 103 funds tracked by Wall St. Rank hold INO as of Q2 2025.

  • Invesco reported no remaining Inovio Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Invesco sold 11,779 Inovio Pharmaceuticals shares in Q2 2025, an estimated $19.2K.
  • Invesco first reported a position in Inovio Pharmaceuticals in Q4 2013 and held it in 38 quarters.
  • Invesco's Inovio Pharmaceuticals position peaked at $7.43M in Q3 2016.
  • 103 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2025.

Based on Invesco's 13F filing for Q2 2025, filed 13 Aug 2025.